In these systems, LSC burden decreased commensurate with GLI2 and cell cycle regulatory gene repression and while GLI2 overexpression enhances dormant human leukemia stem cell generation, selective inhibition of SMO abrogates it and sensitizes them to tyrosine kinase inhibitors. This evidence concerns the gene GLI2 and leukemia.